RACGAP1P1 and hepatocellular carcinoma: RACGAP1P has been reported to elicit its oncogenic activity as a ceRNA to competitively sequestrate miR‐15‐5p from its endogenous target RACGAP1, thereby leading to the activation of RhoA/ERK signaling and contributing to the recurrence of hepatocellular carcinoma [18].